Rivista
/
Bioingegneria
/
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
JoVE Journal
Bioingegneria
È necessario avere un abbonamento a JoVE per visualizzare questo.  Accedi o inizia la tua prova gratuita.
JoVE Journal Bioingegneria
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

DOI:
10.3791/55461-v

•

10:39 min

•

April 15, 2017

•

, , , , , ,
1Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center,University Medical Center Hamburg-Eppendorf and DZHK (German Center for Cardiovascular Research)

Capitoli

  • 00:05Titolo
  • 01:05Engineering Heart Tissue (EHT) Generation
  • 03:40Contraction Analysis
  • 05:48Drug Screening
  • 08:20Results: Representative EHT Contraction Analysis
  • 09:32Conclusion

Summary

Traduzione automatica

Traduzione automatica

Here, we show the generation of human engineered heart tissue from induced pluripotent stem cells (hiPSC)-derived cardiomyocytes. We present a method to analyze contraction force and exemplary alteration of contraction pattern by the hERG channel inhibitor E-4031. This method shows high level of robustness and suitability for cardiac drug screening.

Tags

Cardiac Drug Safety ScreeningContractile ForceIn Vitro Contraction AnalysisDisease ModelingSafety PharmacologyGene VariantsAgarosePDMS RacksCardiomyocytesFibrinogenThrombinEHT Medium

Article

Embed

AGGIUNGI ALLA PLAYLIST

Usage Statistics

Video correlati

Bioluminescence Imaging for Assessment of Immune Responses Following Implantation of Engineered Heart Tissue (EHT)

Self-reporting Scaffolds for 3-Dimensional Cell Culture

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Hollow Fiber Bioreactors for In Vivo-like Mammalian Tissue Culture

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Read Article